Table 4.
Diagram showing percentage of clinical and paraclinical outcome achieved in the study cohort
| Duration of follow-up (years) | Median (IQR; AR) | 3.7 (1.8–6.1; 0.3–17.4) |
| Headache | n | 104 |
| Headache-free | n (%) | 25 (24.0) |
| Persistent headache | n (%) | 79 (76.0) |
| Improveda | n (%) | 60 (75.9) |
| Visual acuity | n | 110 |
| Abnormal | n (%) | 17 (15.0) |
| Worse eye (logMAR) | Median (IQR; AR) | −0.1 (−0.1–0.0; −0.1–2.0) |
| Change of visual acuity in worse eye (logMAR)a | Median (IQR; AR) | 0.0 (−0.1–0.0, −0.4–1.0) |
| Worseneda (> +0.2 logMAR) | n (%) | 5 (4.5) |
| Improveda (> −0.2 logMAR | n (%) | 5 (4.5) |
| Perimetry (n = 106) | ||
| Abnormal | n (%) | 57 (49.6) |
| Mean deviation of worse eye (dB) | Median (IQR; AR) | −0.8 (−5.2–−0.3; −33.9–1.3) |
| Change of mean deviation of worse eye (dB)a | Median (IQR; AR) | 1.6 (0.1–3.6; −10.8–25.4) |
| Worsened (> −2 dB)a | n (%) | 8 (8.1) |
| Improved (> +2 dB)a | n (%) | 27 (23.9) |
| Fundoscopy (n = 109) | ||
| Abnormal | n (%) | 64 (59.3) |
| Worseneda | n (%) | 5 (4.6) |
| Improveda | n (%) | 62 (57.4) |
| Optical coherence tomography (n = 95) | ||
| pRNFL thickness (µm) | Median (IQR; AR) | 99 (87–110; 29–245) |
| Change of pRNFL (µm)a | Median (IQR; AR) | −105 (−202–−30; −504–21) |
| GCL volume (mm3) | Median (IQR; AR) | 1.05 (0.94–1.10; 0.62–1.13) |
| Change of GCL volume (mm3)a | Median (IQR; AR) | −0.05 (−0.14–−0.03; −0.52–0.09) |
| Ultrasonography (n = 76) | ||
| ONSD > 4.5 mm and/or bat sign | n (%) | 49 (64.5) |
| Normalized ONSD (n = 56) | n (%) | 7 (11.5) |
| ONSD of worse eye (mm) | Median (IQR; AR) | 4.9 (4.3–5.3; 3.0–6.3) |
AR absolute range, dB decibels, GCL ganglion cell layer, IQR interquartile range, logMAR logarithm of the minimum angle of resolution, ONSD optic nerve sheath diameter, pRNFL peripapillary retinal nerve fiber layer
acompared to baseline